English | Español
Patient Daily | Mar 30, 2026

Ohio State Health & Discovery discusses cognitive behavioral therapy for weight loss
Patient Daily | Mar 30, 2026

Lung cancer survivors and advocates to meet Congress for research and care funding
Patient Daily | Mar 30, 2026

Validated mechanisms and strong data emphasized in longevity investing, experts say
Patient Daily | Mar 30, 2026

Sanofi announces partnership with Kali Therapeutics in $1 billion immunology deal
Patient Daily | Mar 30, 2026

Pfizer expresses confidence in Lyme vaccine after mixed Phase 3 trial results
Patient Daily | Mar 30, 2026

Oryon announces $42 million funding for Parkinson’s cell therapy development
Patient Daily | Mar 30, 2026

FDA warns of seizure risk linked to Parkinson’s drugs with levodopa and carbidopa
Patient Daily | Mar 30, 2026

Earendil Labs secures $787 million for AI-driven biologics development

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

AstraZeneca announces Shanghai cell therapy manufacturing base to support China strategy